SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-012322
Filing Date
2024-02-07
Accepted
2024-02-07 17:24:07
Documents
71
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K vktx-20231231.htm   iXBRL 10-K 2659176
2 EX-10.11 vktx-ex10_11.htm EX-10.11 33758
3 EX-23.1 vktx-ex23_1.htm EX-23.1 3488
4 EX-31.1 vktx-ex31_1.htm EX-31.1 15049
5 EX-31.2 vktx-ex31_2.htm EX-31.2 15028
6 EX-32.1 vktx-ex32_1.htm EX-32.1 11860
7 EX-97 vktx-ex97.htm EX-97 55209
8 GRAPHIC img253267218_0.jpg GRAPHIC 120148
  Complete submission text file 0000950170-24-012322.txt   10701136

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT vktx-20231231.xsd EX-101.SCH 1258246
73 EXTRACTED XBRL INSTANCE DOCUMENT vktx-20231231_htm.xml XML 1955365
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37355 | Film No.: 24605905
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)